1760084330
The Longevity Show with Dr. Hillary Lin

Advertise on podcast: The Longevity Show with Dr. Hillary Lin

Rating
★★★★★
5
from
6 reviews
This podcast has
109 episodes
Language
English
Explicit
No
Date created
2024/07/30
Latest episode
2026/11/04
Average duration
43 min.
Release period
16 days

Description

Longevity is about choice. Stanford-trained, board-certified internist Hillary Lin explores the medicine, science and technologies expanding what we can do with our lives. Through conversations with clinicians, researchers and builders, and her own experience in practice, she explains promising tools, real tradeoffs and the decisions behind better health. Hillary is co-founder and CEO of CareCore and writes The Longevity Letter. More years. More choices. Explore the show and free resources at hillarylinmd.com/podcast. Educational content, not personal medical advice.

Unlock The Longevity Show with Dr. Hillary Lin podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from The Longevity Show with Dr. Hillary Lin podcast


Could Your Own Cells Rebuild Fragile Bones? | Dr. Robert Sackstein
2026/11/04
A simple cough can cause a fracture when osteoporosis has made bones fragile. What would it take to rebuild them? I’m joined by Dr. Robert Sackstein, a bone-marrow transplant physician and pioneer of translational glycobiology. He discovered HCELL and developed GPS, a method for changing sugars on living cells to help them enter tissue. We follow that work from a question his mentor could not answer to animal experiments and a first study in ten women with advanced osteoporosis. Robert also shares the story of his mother, the concert pianist whose fractures made the search for better care deeply personal. In this conversation: how bone renews itself, why getting cells into tissue matters, what the early human study observed, and what a controlled trial still needs to establish. This is an exciting question about bone repair, with important work still ahead. Chapters: 00:00 Why Fragile Bones Need Better Answers 01:08 What Stem Cells Do in Bone Repair 05:20 How Cells Find Their Way Into Tissue 07:51 The Discovery Behind the “GPS” Method 16:46 The Personal Story Behind the Research 20:16 What the First Human Study Found 28:26 Cell Aging, Stem Cell Storage & Other Applications 33:14 From Early Results to the Next Trials Study: https://doi.org/10.1016/j.cell.2026.08.017 Trial record: https://clinicaltrials.gov/study/NCT02566655 Dr. Sackstein's discovery account: https://pmc.ncbi.nlm.nih.gov/articles/PMC4847618/ This Phase 1 study included ten women, had no control group, and continued osteoporosis care. It does not establish a cure, the size of a treatment benefit, or rare-event safety. Educational discussion, not personal medical advice. Discuss treatment with your clinician; do not stop prescribed medication because of this interview.
The AI Health Answer You Want Could Be Wrong
2026/10/23
Can you trust ChatGPT with medical advice? Dr. Michael Turken and I explain how to check AI health answers, verify their sources, spot missing context, and decide what to do when AI and your doctor disagree. Dr. Michael Turken, MD, MPH, is a practicing internist at UCSF and the founder and CEO of My Doctor Friend, an AI health assistant for patients and caregivers navigating complex care. He previously worked in health technology at Google, Forward Health, and Omada Health. Michael and I trained together in internal medicine at Stanford and have been friends ever since. Chapters: 00:00 Can You Trust AI With Your Health? 01:49 From Dr. Google to AI 03:32 Why Patients End Up Managing Their Own Care 05:16 Three Ways AI Can Get It Wrong 06:31 Confabulation and Hallucinations: When AI Makes Things Up 10:01 AI Memory and Context Limits 13:08 Sycophancy: When AI Tells You What You Want to Hear 15:52 AI, Medical Triage, and Real-World Risks 19:35 Building a Harness Around AI 22:15 Using AI to Navigate Healthcare 27:10 Practical Ways to Get Better AI Answers MICHAEL TURKEN, MD, MPH + MY DOCTOR FRIEND My Doctor Friend: https://mydoctorfriend.ai/r/lin Offer: Use the referral link or code “lin” for one month of premium access, with no redemption deadline. After that, continue with the free plan (10 messages per month) or choose a paid plan. Learn more about My Doctor Friend: https://about.mydoctorfriend.ai Disclosure: This channel may receive compensation if you make a paid purchase through the My Doctor Friend link or code, at no added cost to you. YouTube: https://www.youtube.com/@DrMichaelTurken LinkedIn: https://www.linkedin.com/in/michaelturken/ Sovereign Care: https://michaelturken.substack.com/ WE DISCUSS AI hallucinations and real citations attached to wrong answersWhat AI remembers about your medical history and what it missesSycophancy: when a chatbot agrees with you too readilyWhat to check when AI and your doctor disagreeWhy patients managing complex care need better tools THREE PROMPTS FROM THE CONVERSATION “Why could you be wrong?” “What do you know about me?” “Don't guess. Look it up.” Compare an AI-generated health summary with your current records and open the sources yourself. Agreement between models doesn't prove an answer is right. Subscribe for more conversations about health, AI and longevity. More from Dr. Hillary Lin: https://hillarylinmd.com/
The Drug Lowered Lp(a). So Why Didn't the Trial Prove a Heart Benefit?
2026/10/09
My patient hiked, lifted weights, and watched what he ate. He still needed a heart stent. High Lp(a) was a big risk factor. So when pelacarsen's HORIZON trial lowered Lp(a) but still “failed”, I wanted to know what that meant for someone like him. In this episode, I explain what the trial actually tested, what we still don't know, and why the timing of prevention matters. I also look at the FDA's approval of an oral PCSK9 pill to lower LDL, the limits of biological-age scores, and what I'd still do with a high Lp(a) result today. Could starting earlier change the answer? Maybe. It doesn't let us assume a drug works. The full results, including harms, still matter. Chapters: 00:00 A Fit Patient Who Still Needed a Stent 00:45 What HORIZON's Result Means 03:26 Why Lp(a) Still Matters 05:17 How Much Lowering, and When? 07:54 Earlier Prevention and Lifetime Risk 10:45 FOURIER: When LDL Lowering Did Reduce Events 15:13 What a Big Trial Can Leave Unanswered 18:37 Why the LDL Pill Got Approved 20:44 Biological Age: Prediction vs. Intervention 21:19 What I'd Do With High Lp(a) 25:32 Statins, Niacin, and the Limits of Marker Lowering 26:37 Current Treatment and the Next Trials Get The Longevity Letter and the heart-test guide: https://hillarylinmd.com/heart-tests I'm Hillary Lin,MD, a physician focused on longevity and preventive care. Longevity is about choice. Subscribe for clear explanations of science and medicine to help you make informed health choices today and keep choosing how you live as you age. More years. More choices. This video is for education, not personal medical advice.
Peptides: What I’m Not Seeing in My Patients | Dr. Mayoni
2026/09/22
I’ve heard plenty of big promises about peptides. What I’m seeing in practice is a lot less dramatic, with an important exception: GLP-1s. In this conversation with Dr. Mayoni Gooneratne, we talk about what the evidence can tell us, why the source of an injectable matters, and how GLP-1s fit into conversations about women’s health, nutrition and muscle. We also get into the difference between off-label prescribing, compounded medicines and products sold for research use, and why a promising idea is only one part of the decision. Original conversation hosted by Dr. Mayoni Gooneratne and shared with permission. Learn more about Dr. Mayoni: https://drmhumanhealth.co.uk/dr-mayoni Chapters 00:00 Peptides Beyond GLP-1s 00:25 Off-Label Prescribing & FDA Approval 01:37 Compounding Pharmacies vs. "Research Use" Labs 04:36 Sourcing Safety & Why Batch Testing Matters 06:38 What Can Go Wrong? (ICU Case) 07:34 Beyond Compounds: Lifestyle Medicine First 09:02 Women’s Health, Perimenopause & GLP-1s 11:05 Sustainable Weight Loss & Muscle Preservation 13:48 Final Advice: Beating the Peptide FOMO References: FDA: off-label use — https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label FDA: compounding — https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers FDA: BPC-157 briefing — https://www.fda.gov/media/193343/download This conversation is for education, not personal treatment advice. Discuss medication changes with your clinician.
Your Inflammation Test Is High. Are You Actually Inflamed?
2026/09/17
Your inflammation test is high. Before you try to lower the number, find out what it actually measured. I explain why ESR, CRP, hsCRP and ferritin can tell different stories, what newer tests such as GlycA can add, and why a treatment that lowers a marker still has to prove that people do better. We’ll look at a frightening CRP result that settled on repeat testing, a ferritin result that prompted a closer look, and the heart-disease trials that separate a better lab number from a better outcome. Read the full guide: https://hillarylinmd.com/guides/inflammation-markers-crp-esr-ferritin Clinical examples combine and change details to protect privacy. This is education, not personal medical advice. Interpret your results with your symptoms, history, other tests and clinician. Chapters: 00:00 What a High Inflammation Result Means 00:24 ESR: What the Falling Blood Cells Tell Us 04:41 CRP: Why a High Result Can Disappear 08:42 hsCRP and Cardiovascular Risk 09:23 Ferritin: Iron Stores and Misleading Results 14:02 What hsCRP Predicted, and What JUPITER Tested 18:30 GlycA, Glycan Age and the Limits of Newer Tests 23:03 Do Lower Markers Mean Better Health?
Fake AI Doctors Are Here. Real Doctors Need to Show Up.
2026/09/10
Patients already get health advice from their feeds. What happens when the “doctor” on screen isn't a person? In this Ultralight conversation, Sunita Mohanty and I talk about why real clinicians need a public voice, and how to start when posting feels unnatural and clinic already takes everything you've got. We cover the three layers of a physician's online presence, choosing a platform that fits how you think, using AI for research without handing over your judgment, and why you should make your first videos before paying an agency to make them for you. The point is to build trust with people you can help. Start with why you're posting, learn what works, and keep an audience you can reach beyond an algorithm. Read the companion playbook: https://hillarylinmd.com/guides/social-media-for-physicians For clinicians and health builders, join The CareCore Stack: https://stack.carecore.io/subscribe Chapters 00:00 Fake Doctors And Trust Online 03:49 Why Doctors Hesitate To Post 05:11 The Three Layers Of Clinician Content 08:39 Find Your Why And Choose A Platform 13:28 Why Healthcare Needs More Than Viral Content 15:49 Clinicians As Educators And Storytellers 17:30 Getting Started With AI Research And Stories 24:04 Develop Your Taste Before Hiring An Agency 26:32 Build An Audience Beyond Social Platforms Featuring Hillary Lin, MD, in conversation with Sunita Mohanty of Ultralight.
My LDL Was 192. Then I Found the First PCSK9 Pill.
2026/08/14
My LDL was 192 even though I felt healthy. That result sent me into the story of PCSK9—a protein discovered outside cholesterol research that became the target of injections, RNA silencing, the first oral PCSK9 inhibitor, and now one-time gene-editing experiments. This episode follows the human genetics, LDL-receptor biology, and three engineering problems behind Lipfendra/enlicitide. The pill has proven potent LDL and ApoB lowering; its dedicated cardiovascular-outcomes trial is still ongoing. 𝘋𝘐𝘚𝘊𝘓𝘈𝘐𝘔𝘌𝘙: 𝘛𝘩𝘪𝘴 𝘷𝘪𝘥𝘦𝘰 𝘪𝘴 𝘧𝘰𝘳 𝘦𝘥𝘶𝘤𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘢𝘯𝘥 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘱𝘶𝘳𝘱𝘰𝘴𝘦𝘴 𝘰𝘯𝘭𝘺 𝘢𝘯𝘥 𝘥𝘰𝘦𝘴 𝘯𝘰𝘵 𝘤𝘰𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘦 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘢𝘥𝘷𝘪𝘤𝘦. 𝘈𝘭𝘸𝘢𝘺𝘴 𝘤𝘰𝘯𝘴𝘶𝘭𝘵 𝘸𝘪𝘵𝘩 𝘺𝘰𝘶𝘳 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭 𝘳𝘦𝘨𝘢𝘳𝘥𝘪𝘯𝘨 𝘱𝘦𝘳𝘴𝘰𝘯𝘢𝘭 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘤𝘰𝘯𝘥𝘪𝘵𝘪𝘰𝘯𝘴, 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴, 𝘰𝘳 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘱𝘭𝘢𝘯𝘴. Chapters: 00:00 The Inherited Risk: My LDL Was 192 and the First Oral PCSK9 Is Here 02:36 Nature’s Human Experiment: The Dallas Heart Study & The 88% Risk Drop 05:40 The Zero-PCSK9 Human: What Living with an LDL of 14 Proves 07:10 The Disposal Tag: How PCSK9 Destroys Your Artery Clearance 08:42 The Evolution of PCSK9 Inhibitors: From Antibodies to RNA 12:02 Evolution in a Test Tube: Engineering the First Oral PCSK9 Pill 16:04 The Practical Inversion: Why a Daily Pill Can Be Harder Than an Injection 18:04 One Injection for Life: The Promise and Risk of Permanent Gene Editing 21:12 What This Means for You: Managing Family History, Risk, and Daily Reality
What Human Longevity Found After Screening 10,000 “Healthy” People
2026/08/04
A corrected version of this episode is here: https://youtu.be/SG1aq_6vkFI What happens when you run deep, whole-body imaging and genetic sequencing on 10,000 people who feel completely healthy? Dr. Wei-Wu He, Chairman and CEO of Human Longevity, Inc. (HLI), joins Dr. Hillary Lin to break down the realities of precision medicine and the hidden risks lurking in asymptomatic patients. They discuss why standard population medicine might miss your individual risk, how polygenic risk scores are changing cardiovascular prevention, and his vision for democratizing these life-saving screenings for everyone. About the Guest:  Dr. Wei-Wu He is the Chairman and CEO of Human Longevity, Inc. (HLI), bringing over 40 years of experience in molecular biology and biotechnology to the forefront of proactive healthcare. A seasoned biotech entrepreneur and investor, his career has been dedicated to advancing genomics and precision medicine. Under his leadership, HLI is combining whole-genome sequencing, advanced imaging, and artificial intelligence to democratize data-driven, preventative medicine and extend the human healthspan. Disclaimer: The patient outcomes and case studies discussed in this episode are company-reported observational findings by Human Longevity, Inc., not independently verified clinical trials. Screening data should always be interpreted by a qualified clinician. A test earns its place when it changes a medical decision and includes a responsible follow-up plan. Chapters: 00:00 What Happens When Healthy People Get Screened? 00:21 The Silent Risks: Aneurysms, Tumors, and Arterial Plaque 03:04 The Compound Effect of "Rare" Diseases 05:09 Lifespan Heritability: Is 50% of Your Life Predetermined? 05:48 Monogenic vs. Polygenic Risk Scores (PRS) 06:49 Predicting Heart Attack Risk 12 Years in Advance 10:52 Family History vs. Your Actual Genome 12:46 Inside HLI: The CEO's Vision for Data Collection 14:13 Case Study: Stool-DNA, Colonoscopy, and Appendiceal Cancer 17:04 Population Medicine vs. Individual Risk Dr. Lin's Longevity Tips & Newsletter: hillarylinmd.com/go/ytLinkedIn: linkedin.com/in/hillarylinmdAbout Dr. Hillary Lin: hillarylinmd.comExplore CareCore: carecore.ioHuman Longevity, Inc (HLI): https://www.humanlongevity.com/
The Fitness Decline You Won’t See Coming (Even With “Good” Labs)
2026/07/20
Your annual blood work looks perfect—but what happens when you hit a physical stressor, catch a virus, or simply start aging? Most standard labs are designed to detect disease, but they completely miss your physiologic reserve. In this episode, Dr. Hillary Lin sits down with Brooks Leitner to discuss why VO₂ max should be treated as a clinical vital sign. Using VO Health’s early-stage blood-based proteomics as a fascinating case study, we dive into how the body actually delivers oxygen under stress, why wearable estimates aren't the whole truth, and how you can actually build a "bad-day buffer" for your long-term health. 🔍 What We’ll Cover The "Normal Labs" Trap: Why perfect blood work can hide dangerously low physical reserve.Your "Bad-Day Buffer": How to build resilience for unexpected physical stress like illness or surgery.The Missing Vital Sign: Why fitness should be checked right alongside your blood pressure.Oxygen Under Stress: What VO₂ max actually measures across your entire cellular engine.The Mortality Signal: The data linking higher fitness to a longer life, and what the studies really mean.VO₂ Max Blind Spots: Why cardio alone isn't enough to build true physical resilience.Data vs. Reality: Why mismatches between your smartwatch and your actual performance are valuable signals.Where to Start: A practical, zero-equipment method to start building your reserve today. Chapters 00:00 Why Normal Labs Miss The Mark 00:47 What Routine Blood Work Gets Wrong About Health 02:03 Defining True Resilience And Hormesis 04:34 The Shocking Decline In Population Fitness 06:32 Cardiorespiratory Fitness: The Missing Vital Sign 10:29 The Oxygen Cascade: How VO2 Max Actually Works 12:55 The Surprising Data Linking VO2 Max To Mortality 15:50 Improving VO2 Max: Is It Possible? 17:55 Weight Loss, Muscle Mass, And Gaming Your VO2 Max 23:54 Heart Rate Training Zones And The Problem With METs 29:21 Why Endurance Training Won't Maximize Your VO2 Max 32:00 What VO2 Max Completely Misses (Strength And Grip) 35:20 Sauna, Altitude, And Drugs For VO2 Max 42:08 Proteomics: Estimating Your VO2 Max From A Blood Test 49:00 Wearables and Their Accuracy in Measuring Fitness 51:53 The Ultimate Zero-Equipment Hack To Build VO2 Max Get Dr. Hillary Lin’s free longevity tips and newsletter: https://hillarylinmd.com/go/yt Learn more about the podcast: https://hillarylinmd.com/podcast LinkedIn: https://www.linkedin.com/in/hillarylinmd/ Learn more about Dr. Hillary Lin: https://www.hillarylinmd.com/ Explore CareCore: https://carecore.io VO Health: https://vohealth.co/
High ApoB, CAC Zero: What Your Heart Tests Are Really Saying
2026/07/13
High ApoB but clean metabolic labs. CAC zero but inherited Lp(a). A normal stress test but plaque on CCTA. This is where heart-disease prevention gets noisy. In this advanced episode, I walk through how I read conflicting heart-risk signals without letting one lab, scan, or internet camp hijack the whole conversation. The map is simple: particle traffic, the artery wall, blood pressure and metabolic terrain, visible plaque, and the clot we are trying to prevent. We cover ApoB, LDL-C, LDL-P, particle size, Lp(a), APOE4, CAC, CCTA, CIMT, stress testing, inflammation, plaque reversal, statin concerns, supplements, and what actually changes the next decision. Use this as education and a framework for better clinician conversations, not a personal treatment plan. Chapters 00:00 Why Heart Tests Seem To Disagree 01:43 The Map: Particles, Wall, Terrain, Plaque, Event 06:22 Where Plaque Actually Begins 10:07 Why Evolution Left Us Vulnerable 13:22 ApoB, LDL-C, LDL-P, Particle Size, Remnants, Lp(a) 25:54 High ApoB With Clean Metabolic Markers 30:51 Blood Pressure, Inflammation, And “Terrain” 35:37 APOE4, Family History, And Inherited Clues 40:38 CAC, CCTA, CIMT, Stress Tests, And AI Plaque Analysis 48:26 How To Read Conflicting Signals In Real Life 50:26 Plaque Reversal, Stabilization, And What Counts As Proof 54:18 Statins, Side Effects, Red Yeast Rice, And Supplement Claims 01:09:45 The Takeaway: Do Not Let One Marker Become The Whole Story
Why One Hormone Test Can Miss the Whole Story
2026/06/10
Hormones are not single data points. Cortisol, progesterone, testosterone, and other hormones change across the day, cycle, sleep, stress, training, and context.In this episode, Dr. Hillary Lin talks with Marina Pavlovic Rivas, cofounder and CEO of Eli Health, about why one annual lab snapshot can miss dynamic physiology — and why more data still needs humility.We cover: saliva testing and what it can/can’t showcortisol curves vs cortisol panicprogesterone/testosterone trackingwellness data vs diagnosticswhy validated at-home testing is hardhow AI in healthcare depends on better inputsEducational only, not medical advice.Chapters: 00:00 The Importance of Hormonal Health00:54 The Data Gap in Hormone Health02:43 The Science Behind At-Home Saliva Testing06:17 Understanding Cortisol and Its Impact12:14 Personalizing Cortisol Data vs. Wearable Tracking Limitations15:05 Identifying Overtraining and "Tired but Wired" States18:43 Expanding into Sex Hormones: Progesterone & Testosterone20:40 Tracking Protocols: Finding Trends vs. Creating Noise23:44 The "Anytime, Anywhere" Design Philosophy24:40 Understanding Cortisol and Performance28:31 Factors Influencing Testosterone Levels31:36 Regulatory Boundaries: Wellness vs. Clinical Diagnostics35:18 The Future of Data in Personalized Medicine37:39 The Realities of Deep-Tech Health R&D39:04 Closing Insights for Longevity and Health-Tech FoundersGet Dr. Hillary Lin’s free longevity tips and newsletter: https://www.hillarylinmd.com/subscribe Learn more about Dr. Hillary Lin: https://www.hillarylinmd.com/ Explore CareCore: https://carecore.io
Your Workout Might Be Making You Older
2026/05/25
What if your workout is making you older? In this episode of The Longevity Show, Dr. Hillary Lin sits down with performance coach Kyle Gonzalez to unpack why longevity training is not just “exercise more.” It is movement throughout the day, recovery, aerobic base, strength, balance, power, glucose control, and building a body that still gives you access to life decades from now.Kyle shares a practical framework for moving more without burning out: why the other 23 hours matter, how to use the 1% rule for exercise, when HIIT helps or backfires, why Zone 2 and walking still matter, how to recover like it is part of training, and what to make of sauna, cold plunge, rucking, barefoot training, HRV, peptides, and more.
The Modern Lipid Playbook Part 3: THE TREATMENT — Every Drug, Every Option, Ranked
2026/05/08
There is a drug in clinical trials right now that could permanently fix your cholesterol with a single infusion. Once. That's where we're headed. But there's also a $4 generic that's saved millions of lives — and a twice-a-year injection most patients have never heard of. I'm a Stanford-trained physician. My ApoB was 128. My grandfather died of a stroke. My grandmother died of cardiac arrest. My father is recovering from a heart transplant. In this video, I break down every lipid-lowering option available — without hedging, without liability speak — so you can have an intelligent conversation with your doctor. WHAT YOU'LL LEARN: Why there's no floor for ApoB — the cholesterol-years concept that changes when you start treatmentThe genetics checkpoint: Lp(a), FH, and ancestry factors that change your drug selection entirelyStatins: muscle pain reality, the nocebo effect (SAMSON trial), SLCO1B1 gene, CAC paradox, diabetes signalEzetimibe: the most underused $15/month drug in lipid medicine (IMPROVE-IT data)Bempedoic acid: why it structurally cannot cause muscle toxicity, and what CLEAR Outcomes provedPCSK9 inhibitors: FOURIER + ODYSSEY data, insurance battle, patient assistance programsInclisiran: twice a year, doctor administers — why adherence changes everythingLp(a) pipeline: pelacarsen, olpasiran, muvalaplin — what's coming for the 1 in 4Obicetrapib: oral pill hitting BOTH LDL and Lp(a)Gene therapy: CRISPR + base editing — one injection, once in your lifeLifestyle: honest ceiling assessment, no guiltA tiered protocol framework using ApoB as the treatment targetWhat to actually say to your doctor — 6 specific questions Chapters: 05:11 Genetics Checkpoint 07:51 Statins 16:16 Ezetimibe 18:45 Bempedoic Acid 25:46 PCSK9 Inhibitors 37:20 Inclisiran 39:46 Lp(a) 44:00 Emerging Therapies + Gene Therapy 52:32 Lifestyle 56:11 Protocol Framework 59:04 What to Say to Your Doctor LINKS: Part 1 — The Disease (Atherosclerosis): https://youtu.be/fX33g1zFZSo Part 2 — The Testing (Why Your Lipid Panel Isn't Enough): https://youtu.be/AtOTY0x3U3I Part 4 — The Genetics: [COMING SOON] Newsletter — The Longevity Letter: https://www.hillarylinmd.com/subscribe Follow me: Instagram: https://instagram.com/hillarylinmd Twitter/X: https://twitter.com/hillarylinmd CareCore (For Clinicians): https://carecore.io DISCLAIMER: This video is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. Drug dosing, insurance coverage, and clinical guidelines referenced in this video may have changed since filming. I am a physician but I am not your physician. KEY STUDIES REFERENCED: CTT Meta-analysis: 170,000+ patients, 22% event reduction per 1 mmol/L LDL (Lancet 2012)IMPROVE-IT: ezetimibe outcomes, 18,000 patients (NEJM 2015)FOURIER: evolocumab, 27,500 patients, LDL median 30 mg/dL (NEJM 2017)FOURIER-OLE: 8.6-year follow-up, no safety signal at LDL 95% Lp(a) reduction (NEJM 2023)Lp(a)HORIZON: pelacarsen outcomes trial, 8,000+ patients, ongoingVERVE-101 heart-1: base editing PCSK9 (Lancet ~2024)NTLA-2001 Phase 1: CRISPR PCSK9 editing (2024)Ference et al.: Mendelian randomization, lifetime LDL (EHJ 2017) #cholesterol #ApoB #statins #PCSK9 #inclisiran #genetherapy #lipids #longevity #heartdisease #preventivemedicine #atherosclerosis #cardiovascular #LDL #lipidplaybook
The Modern Lipid Playbook Part 2: THE TESTING — Why Your Lipid Panel Isn't Enough
2026/04/17
🚨 2026 ACC/AHA Dyslipidemia Guidelines just dropped — the first update in 8 years. Eleven specialty societies declared ApoB and Lp(a) standard of care. The standard lipid panel is officially not enough.My patient "David" did everything right for 25 years. His LDL was in the 40s — below even the NEW aggressive target. His stress test was normal. But his Lp(a), a genetic risk marker no one had ever checked, was nearly 3x the danger threshold. His CAC score: 1,522. His widowmaker artery: 75-99% blocked. Weeks later, he needed an emergent stent.His wife? Same household. CAC: zero. His brother? CAC: 2,700.In this episode, I break down every blood test and imaging test for heart disease — what each one measures, what it misses, and why CCTA (coronary CT angiography) with AI should be first-line imaging for anyone at risk.📋 WHAT YOU'LL LEARN:• Why LDL-C is a calculated estimate from a 1972 equation — and why it misses 1 in 5 patients• ApoB — the $15 test now in the formal clinical risk algorithm• Lp(a) — the genetic marker every adult should know (universal screening recommended)• Why "passing a stress test" may be the most dangerous false reassurance in cardiology• CAC scores — useful but completely blind to the plaque most likely to kill you• CCTA + AI — how it cut heart attacks 41% in SCOT-HEART (sustained at 10 years)• CPT 75577 — AI plaque analysis is now covered by Medicare (effective Jan 2026)• A tiered testing playbook with real costs and insurance tips• How to talk to your doctor when they won't order the right testsChapters: 00:00 25 Years on a Statin — and Still Missed00:27 The 2026 Guidelines Changed the Standard01:56 The Standard Lipid Panel’s 1972 Flaw06:38 ApoB and Lp(a): The Two Tests That Change the Story13:24 The Truth About Advanced Panels, HDL, & Triglycerides16:30 The Metabolic Fire: Fasting Insulin & hs-CRP20:18 Why “Passing a Stress Test” Creates Dangerous False Reassurance27:19 The CAC Score: Useful, but Blind to Soft Plaque33:30 CCTA & AI: The New Gold Standard for Plaque Detection42:15 Insurance Coverage, Microvascular Disease, and Who Gets Missed46:29 The Tiered Testing Hierarchy & Your Personal Playbook
The Toxic Wellness Myths Aging You Faster (Cycle Syncing, Plastics & Noise) with Non-Toxic City Girl
2026/04/07
Think the smog outside your city window is the biggest threat to your longevity? Think again. The air inside your kitchen—and the noise from your street—are likely doing significantly more damage to your cellular health.In this episode of The Longevity Show, I sit down in the Tribeca studio with Jiyeon, the brilliant mind behind NonToxicCityGirl. We cut through the noise of the modern wellness industry to discuss what actually moves the needle for your health and what is just an expensive distraction.We dive deep into "rational biohacking," why the traditional medical system is structurally broken, and how agentic AI is about to change how we advocate for our own health. We also dismantle popular wellness myths (like cycle syncing), uncover the real reasons behind generational fertility decline, and share practical protocols for detoxing your daily routine—from "house burping" and navigating the microplastics in your takeout, to the surprising longevity benefits of walking on a treadmill desk.If you want to protect your metabolic health and take agency over your own longevity, this episode is your blueprint. Hit subscribe so you never miss an update, and share this with a friend who needs to cut through the wellness noise!*Chapters:*00:49 Demographics of Longevity and Health Trends03:03 Rational Biohacking vs. Reckless Experimentation06:49 The Role of AI in Personal Health Research20:03 The 17-Year Gap & The Broken Business of Healthcare25:41 Navigating Health Advice with AI & Critical Thinking36:12 Non-Toxic Living: Pollution, Plastics, and Forever Chemicals47:20 The Ultimate Longevity Tool: Daily Movement51:24 The Global Fertility Crisis & Reproductive Optionality01:08:28 Urban Longevity vs. Modern Hustle Culture01:13:14 Diet, Body Recomposition, & Chronic Inflammation01:21:53 Metabolic Health, Mitochondria, & Wellness Myths

Podcast reviews

Read The Longevity Show with Dr. Hillary Lin podcast reviews


5 out of 5
6 reviews

Podcast sponsorship advertising

Start advertising on The Longevity Show with Dr. Hillary Lin relevant audience podcasts


What do you want to promote?